Y. Ikeda

发表

The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

S. Uchiyama, Takenori Yamaguchi, Y. Ikeda, 2011, Cerebrovascular Diseases.

A Randomized, Double-Blind Study Comparing the Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients with Noncardioembolic Cerebral Infarction

T. Okudera, Y. Fukuuchi, Y. Shinohara, 2007, Cerebrovascular Diseases.

Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis

Eric E. Smith, Deepak L. Bhatt, J. Douketis, 2011, Circulation.

Impact of Carotid Endarterectomy on Medical Secondary Prevention After a Stroke or a Transient Ischemic Attack: Results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Deepak L. Bhatt, E. Ohman, P. Wilson, 2006, Stroke.

One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

Deepak L. Bhatt, K. Shimada, P. Steg, 2009, Journal of the Neurological Sciences.

Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan.

Deepak L. Bhatt, K. Shimada, S. Goto, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies

S. Saito, Takeshi Kimura, H. Ogawa, 2017, Cardiovascular Intervention and Therapeutics.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation Journal.

Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention.

Takeshi Kimura, H. Ogawa, H. Yokoi, 2012, Thrombosis research.

Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.

S. Saito, K. Kitagawa, Takeshi Kimura, 2014, Circulation journal : official journal of the Japanese Circulation Society.

Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention.

Takeshi Kimura, H. Ogawa, H. Yokoi, 2015, Journal of atherosclerosis and thrombosis.

Effects of daily aspirin on cancer incidence and mortality in the elderly Japanese

K. Shimada, N. Ishizuka, S. Uchiyama, 2018, Research and practice in thrombosis and haemostasis.

Statins and Intracerebral Hemorrhage: Collaborative Systematic Review and Meta-Analysis

Eric E. Smith, Deepak L. Bhatt, J. Douketis, 2011, Circulation.

Tolerability, pharmacokinetics, and pharmacodynamics of DX‐9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers

Y. Terada, Y. Ikeda, S. Kunitada, 1999, Clinical pharmacology and therapeutics.

Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial

Takenori Yamaguchi, Y. Ikeda, K. Abe, 2019, Journal of Thrombosis and Thrombolysis.

Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study.

S. Saito, K. Kitagawa, Takeshi Kimura, 2016, Journal of cardiology.

Impact of Carotid Endarterectomy on Medical Secondary Prevention After a Stroke or a Transient Ischemic Attack: Results from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Deepak L. Bhatt, E. Ohman, P. Wilson, 2006, Stroke.

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

Deepak L. Bhatt, Deepak L Bhatt, Shinya Goto, 2006, JAMA.

No association between on-treatment platelet reactivity and bleeding events following percutaneous coronary intervention and antiplatelet therapy: A post hoc analysis.

S. Saito, Takeshi Kimura, H. Ogawa, 2015, Thrombosis research.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years of Older With Atherosclerotic Risk-Factors: A Randomized Clinical Trial

K. Shimada, T. Teramoto, Y. Ikeda, 2015 .

Shear-Induced Platelet Aggregation in Cerebral Ischemia platelet aggregation (SIPA) in patients with cerebral ischemia with a newly developed apparatus and studied

S. Uchiyama, M. Handa, S. Maruyama, 2005 .

Oral Beraprost Sodium as a Prostaglandin I2 Analogue for Vascular Events in Patients with Peripheral Arterial Disease : Meta-Analysis of Two Placebo-Controlled Randomized Trials

K. Shimada, H. Shigematsu, H. Origasa, 2004 .

USE OF THE CHADS2 AND CHA2DS2-VASC SCORE IN JAPANESE PATIENTS WITH ATRIAL FIBRILLATION: A SUB-ANALYSIS OF THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY OR CEREBROVASCULAR EVENTS (J-TRACE)

G. Lip, K. Kitagawa, S. Goto, 2012 .

The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE): a nation-wide, prospective large cohort study; the study design.

K. Shimada, S. Goto, S. Uchiyama, 2008, Circulation journal : official journal of the Japanese Circulation Society.

Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study

K. Sugano, K. Shimada, S. Goto, 2011, Cardiovascular Drugs and Therapy.

With Atherothrombosis One-Year Cardiovascular Event Rates in Outpatients

Deepak L. Bhatt, R. D'Agostino, P. Wilson, 2007 .

Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry.

K. Shimada, K. Kitagawa, S. Goto, 2010, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Deepak L. Bhatt, R. D'Agostino, P. Wilson, 2008, American heart journal.

Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study.

S. Saito, K. Kitagawa, Takeshi Kimura, 2015, International journal of cardiology.

One-year cardiovascular event rates in outpatients with atherothrombosis.

Deepak L. Bhatt, M. Pencina, R. D'Agostino, 2007, JAMA.

Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II

A. Ogawa, K. Kitagawa, T. Kitazono, 2020, Cerebrovascular Diseases.

Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study

Hideki Origasa, Toshifumi Hibi, Takashi Kawai, 2019, Heart and Vessels.

Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel

A. Ogawa, T. Kitazono, Y. Ikeda, 2018, Journal of Thrombosis and Thrombolysis.

Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study

K. Sugano, K. Shimada, S. Goto, 2013, Journal of Gastroenterology.

Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry

Deepak L. Bhatt, P. Amarenco, S. Goto, 2014, European journal of preventive cardiology.

K. Shimada, S. Goto, S. Uchiyama, 2010, Circulation journal : official journal of the Japanese Circulation Society.

Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis.

Deepak L. Bhatt, K. Eagle, M. Krempf, 2015, European heart journal.

Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project

K. Shimada, N. Ishizuka, S. Uchiyama, 2016, Stroke.

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

K. Shimada, N. Ishizuka, S. Uchiyama, 2014, JAMA.

Blood Pressure Level and Variability During Long-Term Prasugrel or Clopidogrel Medication After Stroke

A. Ogawa, K. Kitagawa, T. Kitazono, 2021, Stroke.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)

K. Shimada, N. Ishizuka, S. Uchiyama, 2018, American Journal of Cardiovascular Drugs.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or OlderWith Atherosclerotic Risk Factors A Randomized Clinical Trial

K. Shimada, N. Ishizuka, S. Uchiyama, 2014 .

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)

A. Ogawa, K. Kitagawa, T. Kitazono, 2019, The Lancet Neurology.

Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry

Deepak L. Bhatt, K. Eagle, P. Steg, 2016, Clinical cardiology.

A Randomized Trial of E5510 versus Aspirin in Patients with Transient Ischemic Attacks

M. Fujishima, Y. Shinohara, H. Tohgi, 1995, Angiology.

A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial – PRASTRO-I trial

A. Ogawa, K. Kitagawa, T. Kitazono, 2018, Expert opinion on pharmacotherapy.

Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial

A. Ogawa, K. Kitagawa, T. Kitazono, 2020, Journal of atherosclerosis and thrombosis.

Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events.

K. Shimada, N. Ishizuka, N. Yamada, 2010, American heart journal.

Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks

K. Shimada, N. Ishizuka, S. Uchiyama, 2019, Journal of hypertension.

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.

Deepak L. Bhatt, R. D'Agostino, E. Ohman, 2008, American heart journal.

Statins and Intracerebral Hemorrhage Collaborative Systematic Review and Meta-Analysis

Sydney, Eric E. Smith, Deepak L. Bhatt, 2011 .